CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35 enrolled
Drug / intervention
Nucleus Hybrid L24 Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02379273
NCT02379273N/ACompleted
CompareCT.gov

The Nucleus Hybrid L24 Implant System: Extended Duration Post Approval Study

Cochlear·interventional·Posted Mar 4, 2015·Updated Nov 30, 2021

In Brief

A clinical study evaluating Nucleus Hybrid L24 Implant for Hearing Loss. Completed, enrolled 35 participants.

Detailed Summary

This post approval study evaluates the long term safety and efficacy of the Nucleus Hybrid L24 Implant System in a group of already implanted recipients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
Countries--
CollaboratorsUniversity of Iowa, NYU Langone Health, Midwest Ear Institute, University of Cincinnati, The Center for Hearing and Balance Disorders, Ohio State University, Mayo Clinic, Hearts for Hearing

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 4, 2015
Enrollment StartJan 14, 2015
Primary CompletionMar 18, 2019
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 11.3 years ago

Interventions

Nucleus Hybrid L24 Implantdevice

Subjects have already been implanted with the Nucleus Hybrid L24 implant.